Matching slides 303,780
Current window 204,781-204,810
Pages 10,126
Rows per page 30
Component: Titleclear collectionreset all

Component

204,781-204,810 of 303,780

filter-aware
11
The slide outlines the clinical trial structure, including patient eligibility criteria and study objectives for both phases.Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
12
The slide uses a process-flow style diagram to show how initial cohorts are expanded via back-filling and then filtered into a response-evaluable population.Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
13
The slide presents baseline patient characteristics and prior treatment history for a clinical trial cohort.Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
14
Data presented at ENA 2022. N=35 patients.Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
15
The chart displays a log-scale y-axis for concentration. The data supports once-daily (QD) dosing based on a 20h half-life.Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
16
Clinical trial data presentation for ENA 2022.Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
17
The chart is a classic waterfall plot used in oncology clinical trials to demonstrate drug efficacy.Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations 1 hit
18
The chart is a swimmer plot (often used in oncology to show duration of response/treatment).Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations 1 hit
19
Includes a spider plot (waterfall-like over time) and a bar chart showing allele clearance.Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations 1 hit
20
The slide uses a before-after-during progression (Baseline, 4 weeks, 8 weeks) to visualize drug efficacy.Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations 1 hit
21
The slide uses a timeline-style list on the left to describe the patient's treatment history and a before-after image grid on the right to show clinical response.Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations 1 hit
23
Nuvalent | Investor Presentation Deck | 31 slidesNuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations 1 hit
26
The slide uses a combination of scatter plots, bar charts, and a waterfall-style selectivity chart to demonstrate drug efficacy and safety profile.Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations 1 hit
27
The slide compares vehicle control vs NVL-655 treatment across multiple cell lines and a patient-derived xenograft (PDX) model.Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations 1 hit
28
The slide uses a structured table to define patient eligibility criteria for different cohorts in a clinical trial.Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations 1 hit
30
The slide uses three distinct chart types to demonstrate drug efficacy and safety profile.Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations 1 hit
31
Slide 31 of a corporate presentation.Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations 1 hit
02
Organicell Regenerative Medicine | Investor Presentation Deck | 17 slidesOrganicell Regenerative Medicine | Investor Presentation Deck | 17 slides · Organicell Regenerative Medicine
Pitch deck Investor relations 1 hit
03
Includes both stock market data and business financial summary in a side-by-side table format.Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides · Organicell Regenerative Medicine
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
04
Organicell Regenerative Medicine | Investor Presentation Deck | 17 slidesOrganicell Regenerative Medicine | Investor Presentation Deck | 17 slides · Organicell Regenerative Medicine
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
05
The slide uses a timeline-based strategic roadmap to outline short, mid, and long-term business goals.Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides · Organicell Regenerative Medicine
Pitch deck Investor relations 1 hit
06
Organicell Regenerative Medicine | Investor Presentation Deck | 17 slidesOrganicell Regenerative Medicine | Investor Presentation Deck | 17 slides · Organicell Regenerative Medicine
Pitch deck Investor relations 1 hit
07
The slide uses a four-column layout to describe the biological composition of each product.Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides · Organicell Regenerative Medicine
Pitch deck Investor relations Beat · Solution1 hit
08
Organicell Regenerative Medicine | Investor Presentation Deck | 17 slidesOrganicell Regenerative Medicine | Investor Presentation Deck | 17 slides · Organicell Regenerative Medicine
Pitch deck Investor relations 1 hit
10
Includes a scientific diagram illustrating the biogenesis of EVs (exosomes, microvesicles, apoptotic bodies).Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides · Organicell Regenerative Medicine
Pitch deck Investor relations Loop · Voice Of Customer1 hit
11
The slide uses two scientific diagrams to illustrate the biological mechanism and molecular content of exosomes.Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides · Organicell Regenerative Medicine
Pitch deck Investor relations 1 hit
13
The slide uses a before-after-bridge structure to demonstrate therapeutic efficacy.Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides · Organicell Regenerative Medicine
Pitch deck Investor relations 1 hit
14
Includes longitudinal patient data and representative imaging.Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides · Organicell Regenerative Medicine
Pitch deck Investor relations 1 hit
15
The slide uses a grid layout to categorize patent statuses (Patent Pending vs Provisional Patent) for four distinct product lines.Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides · Organicell Regenerative Medicine
Pitch deck Investor relations 1 hit
16
Includes logos of partner firms at the bottom.Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides · Organicell Regenerative Medicine
Pitch deck Investor relations Beat · Team1 hit